Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
14 studies found for:    Provectus
Show Display Options
Rank Status Study
1 Completed An Efficacy and Safety Study of PH-10 Aqueous Hydrogel for the Treatment of Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: PH-10 (0.001% Rose Bengal)
2 Completed PV-10 Chemoablation of Recurrent Breast Carcinoma
Condition: Breast Cancer
Intervention: Drug: PV-10 (rose bengal disodium 10%)
3 Completed Randomized Study of PH-10 for Psoriasis
Condition: Psoriasis
Interventions: Drug: PH-10 (0.002% Rose Bengal);   Drug: PH-10 (0.005% Rose Bengal);   Drug: PH-10 (0.01% Rose Bengal);   Drug: Vehicle
4 Completed Intralesional PV-10 Chemoablation of Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: PV-10 (rose bengal disodium, 10%)
5 Active, not recruiting A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10
Condition: Psoriasis
Intervention: Drug: Topical Rose Bengal, 0.005%
6 Completed A Phase 2 Study of PH-10 for the Treatment of Atopic Dermatitis
Condition: Atopic Dermatitis
Intervention: Drug: PH-10
7 Terminated Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: PH-10 (rose bengal disodium 0.001%);   Drug: Control
8 Recruiting PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma
Condition: Melanoma
Interventions: Drug: PV-10;   Drug: Pembrolizumab
9 Recruiting A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver
Condition: Neuroendocrine Tumors Metastatic to the Liver
Intervention: Drug: Rose bengal disodium
10 Recruiting PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma
Condition: Melanoma Recurrent
Interventions: Drug: PV-10 (10% rose bengal disodium);   Drug: Dacarbazine, temozolomide or talimogene laherparepvec
11 Recruiting A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Conditions: Cancer Metastatic to the Liver;   Hepatocellular Carcinoma That is Not Amenable to Resection, Transplant or Other Potentially Curative;   Therapy
Intervention: Drug: PV-10 (10% rose bengal disodium)
12 Completed
Has Results
Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: PV-10 (10% rose bengal disodium)
13 No longer available Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors
Conditions: Cutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory;   Approved Alternative Therapy
Intervention: Drug: PV-10 (10% rose bengal disodium)
14 Completed Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study
Condition: Melanoma
Interventions: Drug: PV-10;   Procedure: Surgery

Study has passed its completion date and status has not been verified in more than two years.